Aperçu

Résumé (français)

Veuillez noter que les résumés n'apparaissent que dans la langue de la publication et peuvent ne pas avoir de traduction.

Résumé (anglais)

This study describes blood plasma concentrations of PCBs and p,p’-DDE in the Canadian population aged 20-79 years. PCBs and p,p’-DDE were measured in 1668 participants in the Canadian Health Measures Survey, Cycle 1 (2007-2009). We investigated how concentrations vary by sociodemographic, anthropometric, and lifestyle variables, identified factors associated with exposures, and evaluated concentrations against health-based guidance values. Congeners of PCB most commonly detected were PCB-138, PCB-153, and PCB-180. p,p’-DDE was detectable in > 99% of the samples. Factors associated with [SUM]PCBs were age, region of birth, frequency of fish consumption, and liver intake (R2 = 58.1%). For p,p’-DDE, significant factors were sex, age, region of birth, household education, and ethnic origin (R2 = 47.0%). PCB concentrations in Canadians were similar to those in the United States, and lower than those reported in Europe. A small percentage equalled or exceeded the Human Biomonitoring value of 3.5 ug/L for PCBs. Few exceedances of the p,p’-DDE biomonitoring equivalent were observed.